continued until disease progression or intolerable adverse reactions.
Sponsors
The Affiliated Tumor Hospital of Guangxi Medical University
Conditions
lung cancer
Phase 4
The prospective, non-interventional clinical study of carelizumab combined with apatinib in the second-line treatment of advanced non-small cell lung cancer
Active, not recruitingChiCTR2000034455
Start: 2020-07-03Updated: 2020-07-06
The prospective, non-interventional clinical study for carelizumab combined with apatinib in the first-line treatment of advanced non-small cell lung cancer
RecruitingChiCTR2000034486
Start: 2020-07-03Updated: 2020-07-13